These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20716057)

  • 21. The prototype of glycogen phosphorylase.
    Chrysina ED
    Mini Rev Med Chem; 2010 Oct; 10(12):1093-101. PubMed ID: 20716055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, molecular modeling and bio-evaluation of cycloalkyl fused 2-aminopyrimidines as antitubercular and antidiabetic agents.
    Singh N; Pandey SK; Anand N; Dwivedi R; Singh S; Sinha SK; Chaturvedi V; Jaiswal N; Srivastava AK; Shah P; Siddiqui MI; Tripathi RP
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4404-8. PubMed ID: 21737274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments.
    Somsák L; Nagya V; Hadady Z; Docsa T; Gergely P
    Curr Pharm Des; 2003; 9(15):1177-89. PubMed ID: 12769745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies.
    Ihmaid S
    Molecules; 2018 May; 23(6):. PubMed ID: 29844263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoglycemic effects and constituents of the barks of Cyclocarya paliurus and their inhibiting activities to glucosidase and glycogen phosphorylase.
    Li S; Li J; Guan XL; Li J; Deng SP; Li LQ; Tang MT; Huang JG; Chen ZZ; Yang RY
    Fitoterapia; 2011 Oct; 82(7):1081-5. PubMed ID: 21784137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycogen phosphorylase inhibitors: a patent review (2008 - 2012).
    Gaboriaud-Kolar N; Skaltsounis AL
    Expert Opin Ther Pat; 2013 Aug; 23(8):1017-32. PubMed ID: 23627914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of diabetes mellitus. New developments and hopes].
    Verspohl EJ
    Med Monatsschr Pharm; 2005 Jun; 28(6):193-202; quiz 203. PubMed ID: 15960421
    [No Abstract]   [Full Text] [Related]  

  • 28. Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors.
    Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Darji B; Siriki Y; Bandyopadhyay D; Joharapurkar A; Kshirsagar S; Patel H; Shaikh M; Sairam KV; Patel P
    ChemMedChem; 2011 Jun; 6(6):1011-6. PubMed ID: 21506278
    [No Abstract]   [Full Text] [Related]  

  • 29. Phytogenic Polyphenols as Glycogen Phosphorylase Inhibitors: The Potential of Triterpenes and Flavonoids for Glycaemic Control in Type 2 Diabetes.
    Leonidas DD; Hayes JM; Kato A; Skamnaki VT; Chatzileontiadou DS; Kantsadi AL; Kyriakis E; Chetter BA; Stravodimos GA
    Curr Med Chem; 2017; 24(4):384-403. PubMed ID: 27855623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.
    Kristiansen M; Andersen B; Iversen LF; Westergaard N
    J Med Chem; 2004 Jul; 47(14):3537-45. PubMed ID: 15214781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of novel oleanolic acid derivatives as potential antidiabetic agents.
    Zhang L; Jia X; Dong J; Chen D; Liu J; Zhang L; Wen X
    Chem Biol Drug Des; 2014 Mar; 83(3):297-305. PubMed ID: 24119242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural flavonoids as antidiabetic agents. The binding of gallic and ellagic acids to glycogen phosphorylase b.
    Kyriakis E; Stravodimos GA; Kantsadi AL; Chatzileontiadou DS; Skamnaki VT; Leonidas DD
    FEBS Lett; 2015 Jul; 589(15):1787-94. PubMed ID: 25980608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycogen phosphorylase-a is a common target for anti-diabetic effect of iridoid and secoiridoid glycosides.
    Vaidya HB; Ahmed AA; Goyal RK; Cheema SK
    J Pharm Pharm Sci; 2013; 16(4):530-40. PubMed ID: 24210061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
    Andersen B; Westergaard N
    Biochem J; 2002 Oct; 367(Pt 2):443-50. PubMed ID: 12099891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzamide derivatives as dual-action hypoglycemic agents that inhibit glycogen phosphorylase and activate glucokinase.
    Zhang L; Li H; Zhu Q; Liu J; Chen L; Leng Y; Jiang H; Liu H
    Bioorg Med Chem; 2009 Oct; 17(20):7301-12. PubMed ID: 19758809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New pentacyclic triterpenes from Gypsophila oldhamiana and their biological evaluation as glycogen phosphorylase inhibitors.
    Luo JG; Liu J; Kong LY
    Chem Biodivers; 2008 May; 5(5):751-7. PubMed ID: 18493961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New hepatic targets for glycaemic control in diabetes.
    Agius L
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):587-605. PubMed ID: 18054737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged inhibition of glycogen phosphorylase in livers of Zucker Diabetic Fatty rats models human glycogen storage diseases.
    Floettmann E; Gregory L; Teague J; Myatt J; Hammond C; Poucher SM; Jones HB
    Toxicol Pathol; 2010 Apr; 38(3):393-401. PubMed ID: 20215584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle.
    Baker DJ; Timmons JA; Greenhaff PL
    Diabetes; 2005 Aug; 54(8):2453-9. PubMed ID: 16046314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Robust glycogen shunt activity in astrocytes: Effects of glutamatergic and adrenergic agents.
    Walls AB; Heimbürger CM; Bouman SD; Schousboe A; Waagepetersen HS
    Neuroscience; 2009 Jan; 158(1):284-92. PubMed ID: 19000744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.